Trial intelligence / Profile preview

Tarka vs Lotrel in Diabetic Nephropathy

NCT00234871Phase 4Completed

Sponsor
Abbott Laboratories
Start
Jan 2004
Primary completion
Mar 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of trandolapril + verapamil in diabetic nephropathy (DN), hypertension (HTN), sponsored by Abbott Laboratories. Started Jan 2004; status: completed.

02

Drugs

trandolapril + verapamil
03

Conditions

diabetic nephropathy (DN)hypertension (HTN)

Beyond the preview

Go deeper on NCT00234871.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00234871.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call